| Literature DB >> 28777943 |
Elie El Agha1, Rafael Kramann2, Rebekka K Schneider3, Xiaokun Li4, Werner Seeger5, Benjamin D Humphreys6, Saverio Bellusci7.
Abstract
Fibrosis is associated with organ failure and high mortality and is commonly characterized by aberrant myofibroblast accumulation. Investigating the cellular origin of myofibroblasts in various diseases is thus a promising strategy for developing targeted anti-fibrotic treatments. Recent studies using genetic lineage tracing technology have implicated diverse organ-resident perivascular mesenchymal stem cell (MSC)-like cells and bone marrow-MSCs in myofibroblast generation during fibrosis development. In this Review, we give an overview of the emerging role of MSCs and MSC-like cells in myofibroblast-mediated fibrotic disease in the kidney, lung, heart, liver, skin, and bone marrow.Entities:
Keywords: lineage tracing; mesenchymal stem cells; organ fibrosis
Mesh:
Year: 2017 PMID: 28777943 DOI: 10.1016/j.stem.2017.07.011
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633